Shandong Competitors

Pink Sheets . USA . 
Stock . Shandong Weigao Group
SHWGY Stock  USD 2.27  0.04  1.79%   
Shandong Weigao Group competes with Ansell, Straumann Holding, Utah Medical, AngioDynamics, and Straumann Holding; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. Analyzing Shandong Weigao competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Shandong Weigao to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Shandong Weigao Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Shandong Weigao competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.112.277.27
Details
Intrinsic
Valuation
LowRealHigh
0.102.067.06
Details
Naive
Forecast
LowNextHigh
0.042.027.03
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.062.442.83
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Shandong Weigao. Your research has to be compared to or analyzed against Shandong Weigao's peers to derive any actionable benefits. When done correctly, Shandong Weigao's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Shandong Weigao Group.

Shandong Weigao Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Shandong Weigao and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Shandong and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Shandong Weigao Group does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SAUHF
+ 0.93
SAUHY
NEPH
+ 0.77
CLPBY
NEPH
+ 0.67
ANGO
HOCPY
+ 0.62
SAUHY
CLPBY
+ 0.61
ANGO
NEPH
+ 0.59
UTMD
  
High negative correlations   
CLPBY
- 0.77
ANSLF
NEPH
- 0.74
ANSLF
SAUHF
- 0.56
ATRI
ESLOF
- 0.54
SAUHY
ATRI
- 0.53
SAUHY
ANGO
- 0.45
ANSLF

Risk-Adjusted Indicators

There is a big difference between Shandong Pink Sheet performing well and Shandong Weigao Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shandong Weigao's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANSLF  0.89  0.44  0.00 (9.04) 0.00 
 0.00 
 0.00 
 0.00 
 17.44 
SAUHY  1.71 (0.27) 0.00 (0.44) 0.00 
 0.00 
 2.72 
(4.38)
 12.55 
UTMD  0.71 (0.16) 0.00 (0.07) 0.00 
 0.00 
 1.12 
(1.82)
 7.07 
ATRI  0.39 (0.02) 0.00 (0.36) 0.00 
 0.00 
 0.94 
(1.35)
 6.29 
ANGO  2.10 (0.24) 0.00 (0.02) 0.00 
 0.00 
 3.71 
(4.03)
 18.73 
SAUHF  3.57 (0.17) 0.00 (0.40) 0.00 
 0.00 
 7.03 
(7.79)
 18.80 
CLPBY  1.18 (0.15) 0.00 (0.38) 0.00 
 0.00 
 2.00 
(2.63)
 5.64 
HOCPY  1.39 (0.29) 0.00 (0.13) 0.00 
 0.00 
 2.30 
(3.40)
 9.14 
NEPH  1.80 (0.35) 0.00 (0.67) 0.00 
 0.00 
 2.74 
(4.09)
 11.29 
ESLOF  1.54  0.03 (0.04) 0.47  1.84 
(1.50)
 2.56 
(3.06)
 8.50 
All Fundamental Data

Shandong Weigao Competitive Analysis

The better you understand Shandong Weigao competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Shandong Weigao's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Shandong Weigao's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SHWGY ANSLF SAUHY UTMD ANGO SAUHF CLPBY HOCPY NEPH ESLOF
 1.79 
 2.27 
Shandong
 0.95 
 20.80 
Ansell
 1.83 
 12.79 
Straumann
 0.03 
 65.15 
Utah
 0.43 
 7.02 
AngioDynamics
 1.26 
 124.72 
Straumann
 2.14 
 12.89 
Coloplast
 0.19 
 127.30 
Hoya
 3.21 
 1.51 
Nephros
 1.81 
 241.44 
EssilorLuxottica
Market Volatility
(90 Days Market Risk)
Dangerous
Not too volatile
Not too volatile
Very steady
Slightly risky
Very steady
Very steady
Very steady
Unstable
Very steady
Market Performance
(90 Days Performance)
Insignificant
Good
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Low
Low
Low
Very High
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Strong Sell
Strong Buy
Not Available
Not Available
Not Available
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Sell
Sell
Strong Hold
Cautious Hold
Strong Sell
Cautious Hold
Hold
Strong Sell
Strong Sell
Current Ratio
2.99
2.73
2.84
13.44
2.28
2.84
1.01
4.43
5.27
0.95
Net Asset
30.37 B
2.51 B
2.97 B
135.46 M
317.67 M
2.97 B
34.96 B
992.84 B
11.86 M
59.43 B
Profit Margin
0.18
0.0813
0.22
0.35
-0.83
0.22
0.2
0.23
-0.094
0.0774
EBITDA
2.98 B
226.6 M
594.42 M
24.75 M
(14.29 M)
597.63 M
7.23 B
254.57 B
(1.38 M)
4.72 B
Operating Margin
0.22
0.13
0.27
0.38
-0.13
0.27
0.3
0.29
-0.0975
0.13
Current Valuation
6.75 B
2.74 B
17.87 B
132.81 M
235.05 M
17.87 B
28.84 B
33.23 B
14.96 M
95.39 B
Price To Book
2.18
1.59
9.79
1.78
1.45
9.87
22.46
5.91
1.95
2.08
Retained Earnings
7.93 B
(359.14 M)
N/A
138.34 M
(395.2 M)
811 M
N/A
505.27 B
(144.41 M)
416 M
Current Asset
8.26 B
538.89 M
N/A
32.87 M
146.25 M
588 M
N/A
427.5 B
1.53 M
3.43 B
Five Year Return
1.45
2.21
0.52
1.2
N/A
0.86
2.11
0.9
N/A
1.3
Beta
0.4
0.52
1.15
0.08
0.67
1.15
0.21
0.68
1.19
0.88
Number Of Employees
11.48 K
14 K
9.88 K
169
748
9.88 K
14.5 K
38.38 K
31
186.37 K
Shares Outstanding
1.13 B
127.55 M
1.59 B
3.39 M
40.63 M
158.89 M
2.12 B
356.4 M
10.54 M
445.33 M
Cash Flow From Operations
3.04 B
222 M
560.3 M
22.28 M
(28.16 M)
560.3 M
5.1 B
190.06 B
827 K
4.54 B
Annual Yield
0.0132
0.0273
0.0053
0.0187
N/A
0.0053
0.0246
0.0077
N/A
0.0145
Total Debt
3.46 B
426.3 M
479.84 M
295 K
5.91 M
479.84 M
16.36 B
13.76 B
1.84 M
8.91 B
Return On Equity
0.13
0.1
0.31
0.12
-0.78
0.31
0.75
0.21
-0.16
0.0531
Z Score
1.2
3.6
27.6
N/A
N/A
26.4
0.6
1.2
N/A
5.4
Return On Asset
0.0604
0.0605
0.12
0.0818
-0.0612
0.12
0.17
0.13
-0.0796
0.0317
Book Value Per Share
18.04
12.26
1.1
36.1
4.79
11.0
2.78
2256.63
0.79
85.18
Number Of Shares Shorted
N/A
N/A
N/A
55.26 K
1.13 M
N/A
N/A
N/A
7.69 K
N/A
Current Liabilities
2.36 B
232.1 M
N/A
4.07 M
66.73 M
164 M
N/A
122.39 B
684 K
3.16 B
Total Asset
30.37 B
2.51 B
2.97 B
135.46 M
317.67 M
2.97 B
34.96 B
992.84 B
11.86 M
59.43 B
Debt To Equity
0.2
0.31
0.4
0.003
0.14
0.4
2.83
0.028
0.07
0.37
Last Dividend Paid
0.15
0.55
0.68
1.2
N/A
0.68
20.0
155.0
N/A
2.51
Target Price
N/A
N/A
13.0
N/A
13.0
N/A
N/A
117.95
4.75
211.72
Short Ratio
N/A
N/A
N/A
2.09
2.24
N/A
N/A
N/A
0.04
N/A
Shares Owned By Institutions
N/A
49.04
N/A
73.64
81.33
35.71
0.01
0.04
40.92
27.94
Market Capitalization
7.69 B
2.56 B
22.15 B
220.96 M
285.25 M
21.35 B
24.94 B
37.36 B
15.92 M
82.12 B
Price To Earning
19.07
12.22
37.36
31.38
7.9
18.51
37.95
34.52
-4.51
797.55
Price To Earnings To Growth
N/A
N/A
1.95
N/A
1.87
1.97
3.39
N/A
N/A
1.9
Price To Sales
0.51
1.26
8.3
5.01
0.97
8.3
1.13
0.0506
1.16
3.55
Net Income
2.24 B
158.7 M
396.08 M
16.64 M
(184.35 M)
396.08 M
4.71 B
164.51 B
(1.57 M)
1.46 B
Earnings Per Share
0.33
1.24
0.33
4.28
-6.05
3.32
0.31
3.48
-0.09
4.29
Shares Owned By Insiders
N/A
1.56
N/A
6.89
5.47
33.39
N/A
N/A
12.7
36.17
Revenue
13.15 B
1.95 B
2.02 B
50.22 M
303.91 M
2.02 B
22.58 B
670.33 B
14.24 M
19.82 B
Working Capital
5.9 B
306.79 M
N/A
101.56 M
102.1 M
424 M
N/A
305.12 B
6.29 M
273 M
Cash And Equivalents
7.15 B
206.2 M
737.65 M
69.51 M
24.56 M
737.65 M
854 M
434.47 B
4.18 M
3.76 B
Cash Per Share
6.26
1.64
0.46
19.17
0.31
4.64
0.4
N/A
0.41
8.46
Gross Profit
7.25 B
665.8 M
1.54 B
32.2 M
174.25 M
1.54 B
15.53 B
367.8 B
4.73 M
12.11 B
Day Typical Price
2.27
20.8
12.79
65.34
7.04
127.01
12.89
127.45
1.53
242.96
Accumulation Distribution
N/A
N/A
0.0016
0.0146
0.0197
0.056
0.007
0.0066
0.0321
0.0205
Market Facilitation Index
N/A
N/A
0.02
0.96
0.14
7.39
0.09
0.84
0.05
5.06
Daily Balance Of Power
9.2 T
(9,223,372,036,855)
11.5
(0.02)
0.2143
0.2097
3.0
0.2857
(1.00)
0.8478
Period Momentum Indicator
0.04
(0.20)
0.23
(0.02)
0.03
1.55
0.27
0.24
(0.05)
4.29
Rate Of Daily Change
1.02
0.99
1.02
1.0
1.0
1.01
1.02
1.0
0.97
1.02
Day Median Price
2.27
20.8
12.79
65.43
7.05
128.16
12.9
127.52
1.54
243.72
Price Action Indicator
0.02
(0.10)
0.11
(0.29)
(0.01)
(2.66)
0.13
(0.10)
(0.05)
(0.14)
Coefficient Of Variation
1859.45
591.86
(1,083)
(2,075)
(11,779)
(3,740)
(1,395)
(1,290)
(770.54)
3842.76
Mean Deviation
3.19
0.8933
1.71
0.7055
2.1
3.57
1.18
1.39
1.8
1.54
Jensen Alpha
0.5161
0.4413
(0.27)
(0.16)
(0.24)
(0.17)
(0.15)
(0.29)
(0.35)
0.0293
Total Risk Alpha
(0.51)
0.0385
(0.55)
(0.22)
(0.54)
(0.81)
(0.33)
(0.43)
(0.64)
(0.24)
Sortino Ratio
0.0232
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(0.04)
Downside Variance
42.26
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.67
Standard Deviation
5.13
2.64
2.22
1.08
3.31
4.52
1.42
1.83
2.24
1.88
Kurtosis
2.22
31.29
0.9882
7.26
10.67
(0.47)
(0.74)
0.4412
(0.15)
(0.40)
Potential Upside
9.6
N/A
2.72
1.12
3.71
7.03
2.0
2.3
2.74
2.56
Treynor Ratio
(0.12)
(9.04)
(0.44)
(0.07)
(0.02)
(0.40)
(0.38)
(0.13)
(0.67)
0.4659
Maximum Drawdown
29.15
17.44
12.55
7.07
18.73
18.8
5.64
9.14
11.29
8.5
Variance
26.34
6.96
4.91
1.16
10.93
20.47
2.03
3.36
5.01
3.55
Market Risk Adjusted Performance
(0.11)
(9.03)
(0.43)
(0.06)
(0.01)
(0.39)
(0.37)
(0.12)
(0.66)
0.4759
Risk Adjusted Performance
0.0497
0.1366
(0.06)
(0.03)
0.0012
(0.01)
(0.05)
(0.05)
(0.09)
0.0259
Skewness
0.2924
5.66
(0.53)
1.7
(1.40)
(0.17)
(0.08)
(0.19)
(0.09)
0.1905
Semi Deviation
4.57
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.84
Information Ratio
0.0293
0.1214
(0.15)
(0.16)
(0.05)
(0.05)
(0.16)
(0.15)
(0.19)
(0.04)
Value At Risk
(9.13)
N/A
(4.38)
(1.82)
(4.03)
(7.79)
(2.63)
(3.40)
(4.09)
(3.06)
Expected Short fall
(3.91)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(1.50)
Downside Deviation
6.5
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.92
Semi Variance
20.85
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.38

Shandong Weigao Competition Performance Charts

Five steps to successful analysis of Shandong Weigao Competition

Shandong Weigao's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Shandong Weigao Group in relation to its competition. Shandong Weigao's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Shandong Weigao in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Shandong Weigao's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Shandong Weigao Group, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Shandong Weigao position

In addition to having Shandong Weigao in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Medical Equipment Thematic Idea Now

Medical Equipment
Medical Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Shandong Pink Sheet Analysis

When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY